A Clinical Study of YL205 in Patients With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Albuquerque +10 more locations
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All·Age: 18+
Code: NCT06459973·Phase 1, Phase 2·Recruiting·Listed Jun 2024